Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
The potential for weight loss may vary depending on individual factors such as genetics, lifestyle, and medical history
Tier 2: The Mass Adoption Threshold (The 2026 Target) Price: 3,000 - 5,000/month
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted
The differences and similarities between these drugs and all their brand names are legitimately confusing, said Stanford Medicine endocrinologist Sun Kim, MD
Market Share & Forecast 5.2.1
US$ 23.58
US$ 24.65
US$ 22.09
US$ 24.75
US$ 21.48
US$ 25.34
US$ 28.11
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 25.15
